Patel Naimish bought CRSP
October 26, 2026 · Form 4 insider transaction
Patel Naimish bought 24,000 shares of CRISPR Therapeutics AG at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
24,000
Price
$0.00
Total value
N/A
InsiderPatel Naimish
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 26, 2026
Filing dateOctober 28, 2026
Shares owned after24,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted on October 26, 2026 with respect to 24,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 26, 2026.